| Financial Year |
March 31 2023 |
| Monetary Funds |
359,819,521.57 |
| Held-for-trading Financial Assets |
84,105,189.32 |
| Notes Receivable |
-- |
| Accounts Receivable |
101,489,263.49 |
| Advances to Suppliers |
95,135,719.99 |
| Other Receivables |
9,919,355.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
191,057,485.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,106,057.30 |
| Total Current Assets |
842,632,592.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,055,229.37 |
| Investment Properties |
-- |
| Fixed Assetes |
262,630,657.72 |
| Under-construction Projects |
22,126,986.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,426,625.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,880,728.58 |
| Deferred Income Tax Assets |
11,113,068.64 |
| Other Non-Current Assets |
9,016,013.60 |
| Sub-Total of Non-Current Assets |
354,092,647.33 |
| Total Assets |
1,196,725,239.92 |
| Short-Term Loans |
40,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
102,393,280.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
47,282,540.76 |
| Taxes Payable |
2,884,539.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,877,315.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
418,544.87 |
| Other Current Liabilities |
161,822.93 |
| Sub-Total of Current Liabilities |
256,851,798.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,860,046.34 |
| Total Liabilities |
260,711,845.19 |
| Paid-In Capital(Or Share Stock) |
104,030,000.00 |
| Capital Surplus |
288,335,451.71 |
| Surplus Reserve |
61,632,683.47 |
| LESS:Treasury Stock |
43,927,000.00 |
| Undistributed Profits |
525,021,276.45 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
936,013,394.73 |
| Owner's Equity（Stockholder's Equity） |
936,013,394.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,196,725,239.92 |
